Indication: VONVENDI [von Willebrand factor (recombinant)] is used in adults (age 18 years and older) diagnosed with von Willebrand disease to: treat and control bleeding episodes and prevent excessive bleeding during and after surgery


Efficacy and Safety

Learn more about the data

Treatment and Control of bleeding episodes

Learn how VONVENDI® treated and controlled bleeding

See data

Established Safety Profile

Information about safety findings in VONVENDI clinical studies

Get results
See how it works

How it works

See how VONVENDI works in VWD

See details
Read more about VONVENDI


Learn about an rVWF from Shire

Read more about it